drugset / Trial / NCT01089218

The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines

NCT01089218

Phase 4 Completed 241 enrolled Seoul National University Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Fever can develop after fiberoptic bronchoscopy (FB) in about 2.5 - 16 % of adult patients. We evaluated the impact of oral amoxicillin/clavulanate (AC) on incidence of postbronchoscopic fever and pneumonia.

Timeline

Start
2008-04
Primary completion
2009-01
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 875 mg Oral
Comparator Clavulanate Unknown 125 mg Oral

Indications